Ethyl 3-(2,6-dichloropyridin-3-yl)-3-oxopropanoate, 98%, 100mg

tert-Butyl (2R,3R)-3-hydroxy-2-methylazetidine-1-carboxylate, 98%, 100mg

(S)-2-Amino-2-(4-chloro-3-(trifluoromethyl)phenyl)ethanol hydrochloride, 95.0%, 250mg

Bis(methyldiphenylphosphine)palladium(II) Dichloride (cis- and trans- mixture)>96.0%(T)1g

(1R,2R)-N1,N1,N2,N2-tetramethylcyclohexane-1,2-diamine, 95.0%, 1g

(R)-2-(((Benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoic acid, 95%, 250mg

N,N'-[(2S,2'S)-[(2-Iodo-1,3-phenylene)bis(oxy)]bis(propane-2,1-diyl)]bis(mesitylamide)>96.0%(HPLC)200mg

[(2s)-1-(triphenylmethyl)aziridin-2-yl]methanol, 95%, 500mg

(2-Hydroxyethyl)trimethylammonium Chloride, 95.0%, 2.5kg

Filtration unit with SFCA membrane Pore size 0.45 μm, 150 ml, 150 ml, 50 mm, 12 Piece(s)

Icosanoic acid, 95.0%, 25g

1,10-phenanthroline monohydrate, min. 99%, pa, ACS, 25 g, glass packaging

2-Chloro-5-fluorobenzonitrile>98.0%(GC)5g